Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter

Investor News

Clinical Development News
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
Approvable Letters
Approval and Marketing Clearance
Recalls and Warnings

Deals & Dollars News
Earnings Reports
Mergers and Acquisitions

IPO News

Clinical - Pre-Clinical
Nektar Therapeutics (CA) (NKTR) Presents Positive Preclinical Data On Oral, Peripherally-Acting Kappa Agonist Molecules At 2014 American Academy Of Pain Management Meeting 9/19/2014 8:10:52 AM
Cyclacel Pharmaceuticals, Inc. (CYCC)'s CYC065 CDK Inhibitor Demonstrates Therapeutic Potential In Acute Leukemias With Mixed Lineage Leukemia (MLL) Rearrangements 9/18/2014 10:19:17 AM
BioLineRx Ltd. Presents Positive Preclinical Results In Treatment For AML Patients With FLT3 Mutations 9/17/2014 9:36:05 AM
Alnylam Pharmaceuticals (ALNY) Presents New Pre-Clinical Data With ALN-CC5, A Subcutaneously Administered Rnai Therapeutic Targeting Complement Component C5 In Development For The Treatment Of Complement-Mediated Diseases 9/16/2014 8:56:52 AM
Celator Pharmaceuticals, Inc. Announces Publication Of Preclinical Data For CPX-351 In Acute Lymphoblastic Leukemia Models 9/15/2014 8:07:59 AM
Viamet Pharmaceuticals Receives Orphan Drug Designation For VT-1129 9/11/2014 10:11:08 AM
GlaxoSmithKline (GSK)'s Experimental Ebola Vaccine Protects Monkeys For 10 Months 9/8/2014 6:17:54 AM
Melinta Therapeutics (Formerly known as Rib-X Pharmaceuticals, Inc.) Demonstrates Potent In Vitro Activity Of New Antibiotic Class Against Gram Negative ESKAPE Pathogens 9/8/2014 2:44:44 PM
Arch Therapeutics Announces Positive Preclinical Data From An Independent Study Of AC5 Surgical Hemostatic Device™ 9/8/2014 11:14:24 AM
Novan Therapeutics’s Nitric Oxide Drug Candidate Inhibits Growth Of Papillomavirus In Translational Animal Model 9/8/2014 10:40:06 AM
Shionogi & Co., Ltd. Presents Pre-Clinical And Phase I Results For S-649266, A Novel Siderophore Cephalosporine Antibiotic With Potential To Treat Multidrug-Resistant Gram-Negative Pathogens 9/8/2014 10:34:54 AM
Blueprint Medicines Presents Positive Data On BLU-554 For Hepatocellular Carcinoma 9/8/2014 9:10:23 AM
Melinta Therapeutics (Formerly known as Rib-X Pharmaceuticals, Inc.) And Hartford Hospital Demonstrate Delafloxacin's Potent In-Vitro Activity Against Complicated Urinary Tract Infection Pathogens 9/8/2014 7:39:38 AM
GamaMabs Pharma SA Announces Two Scientific Communications On Its AMHR2 Project 9/4/2014 10:58:10 AM
Sirona Biochem Announces Positive Results In PK Study For Type 2 Diabetes 9/4/2014 11:16:11 AM